Abstract
Several epidemiological studies indicate an inverse relation between plasma cholesterol and the occurrence of cancer. Since we in previous studies have found that certain malignant cell types have an elevated LDL receptor activity, the aim of the present study was to further explore the possibility that an elevated LDL consumption by tumor cells causes hypocholesterolemia. The plasma cholesterol concentrations in patients with acute leukemia were inversely correlated with the rate of receptor-mediated degradation of125I-LDL by the leukemic cells. During chemotherapy, the total plasma and the LDL cholesterol levels increased concomitantly with the reduction in the leukemic cell count in a patient whose leukemic cells exhibited a high rate at receptor-mediated degradation of125I-LDL. In certain patients with inoperable urinary bladder carcinoma, the plasma cholesterol concentration fell as the disease progressed. Studies in breast cancer patients indicate that the number of LDL receptors in the tumor tissue may have prognostic significance. The results are in agreement with the hypothesis that an elevated LDL receptor activity in malignant cells may lead to hypocholesterolemia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
McMichael A J, Jensen O M, Parkin D M, Zaridze D G: Dietary and endogenous cholesterol and human cancer.Epidem Rev 6, 192 (1984).
Feinleib M: Review of the epidemiological evidence for a possible relationship between hypocholesterolemia and cancer.Cancer Res (suppl)43, 2503s (1983).
Oliver M F, Heady J A, Morris J M, Cooper J: WHO cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol; mortality follow-up. Report of the committee of principal investigators.Lancet 2, 379 (1980).
Sidney S, Farquhar J W: Cholesterol, cancer, and public health policy.Am J Med 75, 494 (1983).
Kark J D, Smith A H, Hames C G: Serum retinol and the inverse relationship between serum cholesterol and cancer.Br Med J 284, 152 (1982).
Sporn M B, Newton D L: Chemoprevention of cancer with retinoids.Fedn Proc 38, 2528 (1979).
Rose G, Shipley M J: Plasma lipids and mortality: a source of error.Lancet 1, 523 (1980).
Cambien F, Ducimetiere P, Richard J: Total serum cholesterol and cancer mortality in a middle-aged male population.Am J Epidem 112, 388 (1980).
Peterson B, Trell E: Premature mortality in middleaged men: serum cholesterol as risk factor.Klin Wochenschr 63, 795 (1983).
Brown M S, Kovanen P T, and Goldstein J L: Regulation of plasma cholesterol by lipoprotein receptors.Science 212, 628 (1981).
Brown M S, Goldstein J L: Receptor-mediated endocytosis. Insights from the lipoprotein receptor system.Proc Natl Acad Sci USA 76, 3330 (1979).
Goldstein J L, Brown M S: Familial hypercholesterolemia, in Stanbury J B, Wyngarden J B, Fredrickson D S, Goldstein J L, Brown M S, (eds):The Metabolic Basis of Inherited Disease, 5th ed., pp. 672–712. New York, McGraw-Hill (1983).
Vitols S, Gahrton G, Öst Å, Peterson C: Elevated low-density lipoprotein receptor activity in leukemic cells with monocytic differentiation.Blood 63, 1186 (1984).
Ho Y K, Smith R G, Brown M S, Goldstein J L: Low-density lipoprotein receptor activity in human acute myelogenous leukemia cells.Blood 52, 1099 (1978).
Bases R E, Krakoff I H: Studies of serum cholesterol levels in leukemia.J Reticuloendothel Soc 2, 8 (1965).
Gilbert H S, Ginsberg H: Hypocholesterolemia as a manifestation of disease activity in chronic myelogenous leukemia.Cancer 51, 1428 (1983).
Rudling M, Collins V P, and Peterson C: Delivery of aclacinomycin A to human glioma cellsin vitro by the low density lipoprotein pathway.Cancer Res 43, 4600 (1983).
Gal D, Ohashi M, McDonald P C, Buchsbaum H C, and Simpson E R: Low density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleides in the management of gynecologic neoplasms.Am J Obstet Gynecol 139, 877 (1981).
Hynds S A, Welsh J, Stewart J M, Jack A, Soukop M, McArdle C S, Calman K C, Packard C J, and Shepherd J: Low-density lipoprotein metabolism in mice with soft tissue tumours.Biochim Biophys Acta 795, 589 (1984).
Norata G, Canti G, Ricci L, Nicolin A, Trezzi E, and Catapano A L:In vivo assimilation of low density lipoproteins by a fibrosarcoma tumour line in mice.Cancer Lett 25, 203 (1984).
Rudling M, and Peterson C: A simple binding assay for the determination of low density lipoprotein receptor activity in cell homogenates.Biochim Biophys Acta 833, 359 (1985).
Wieland H, Seidel D: A simple specific method for precipitation of low density lipoproteins.J Lipid Res 24, 904 (1983).
Rudling M, and Peterson C: LDL receptors in bovine tissues assayed as the heparin-sensitive binding of125I-LDL in homogenates — relation between liver LDL receptors and serum cholesterol in the fetus and post term.Biochim Biophys Acta (in press).
Lindquist R, Vitols S, Gahrton G, Öst Å, and Peterson C: Low density lipoprotein receptor activity in human leukemic cells — relation to chromosome aberrations.Acta Med Scand (in press).
Astrin S: The promotor-insertion mechanism of oncogenesis.Proc 73rd AACR Meeting 65 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Peterson, C., Vitols, S., Rudling, M. et al. Hypocholesterolemia in cancer patients may be caused by elevated LDL receptor activities in malignant cells. Med. Oncol. & Tumor Pharmacother. 2, 143–147 (1985). https://doi.org/10.1007/BF02934541
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02934541